Pain relief in neonates: when to use intravenous paracetamolVAN DEN ANKER, John N; TIBBOEL, Dick.Archives of disease in childhood. 2011, Vol 96, Num 6, pp 573-574, issn 0003-9888, 2 p.Article

How to Optimize the Evaluation and Use of Antibiotics in NeonatesJACQZ-AIGRAIN, Evelyne; KAGUELIDOU, Florentia; VAN DEN ANKER, John N et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x-xi, 11117-1128 [12 p.]Article

Pharmacologic Management of the Opioid Neonatal Abstinence SyndromeKRAFT, Walter K; VAN DEN ANKER, John N.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1147-1165 [19 p.]Article

Neonatal and Pediatric Clinical PharmacologyVAN DEN ANKER, John N; COPPES, Max J; KOREN, Gideon et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, 244 p.Serial Issue

A review of pharmaceutical labeling for overdose treatment and toxicity dataMAZER-AMIRSHAHI, Maryann; SOKOL, Gerald; VAN DEN ANKER, John et al.Pharmacoepidemiology and drug safety. 2013, Vol 22, Num 3, pp 319-323, issn 1053-8569, 5 p.Article

Pharmacological research in pediatrics : From neonates to adolescentsRAKHMANINA, Natella Y; VAN DEN ANKER, John N.Advanced drug delivery reviews. 2006, Vol 58, Num 1, pp 4-14, issn 0169-409X, 11 p.Article

In Vivo Glucuronidation Activity of Drugs in Neonates: Extensive Interindividual Variability Despite Their Young AgeALLEGAERT, Karel; VANHAESEBROUCK, Sophie; VERBESSELT, Rene et al.Therapeutic drug monitoring. 2009, Vol 31, Num 4, pp 411-415, issn 0163-4356, 5 p.Article

¹³C-erythromycin breath test as a noninvasive measure of CYP3A activity in newborn infants : A pilot studyDE WILDT, Saskia N; BERNS, Michiel J. P; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2007, Vol 29, Num 2, pp 225-230, issn 0163-4356, 6 p.Article

Information technology cannot guarantee patient safetyDE WILDT, Saskia N; VERZIJDEN, Ron; VAN DEN ANKER, John N et al.BMJ. British medical journal (International ed.). 2007, Vol 334, Num 7598, pp 851-852, issn 0959-8146, 2 p.Article

NONMEM and NPEM2 population modeling: A comparison using tobramycin data in neonatesDE HOOG, Matthijs; SCHOEMAKER, Rik C; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2002, Vol 24, Num 3, pp 359-365, issn 0163-4356Article

Improving Drug Formulations for Neonates: Making a Big Difference in Our Smallest PatientsNOEL, Gary J; VAN DEN ANKER, John N; LOMBARDI, Donald et al.The Journal of pediatrics. 2012, Vol 161, Num 5, pp 947-949, issn 0022-3476, 3 p.Article

Pharmacotherapy for Pulmonary HypertensionSTEINHORN, Robin H.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1129-1146 [16 p.]Article

Emerging Biomarkers of Intrauterine Neonatal and Pediatric Exposures to XenobioticsDELANO, Kaitlyn; KOREN, Gideon.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x, 1059-1070 [11 p.]Article

PHARMACOTHERAPY OF DISRUPTIVE BEHAVIOR IN MENTALLY RETARDED SUBJECTS: A REVIEW OF THE CURRENT LITERATUREHÄSSLER, Frank; REIS, Olaf.Developmental disabilities research reviews. 2010, Vol 16, Num 3, pp 265-272, issn 1940-5510, 8 p.Article

Renal drug clearance in preterm neonates: Relation to prenatal growthALLEGAERT, Karel; ANDERSON, Brian J; VAN DEN ANKER, John N et al.Therapeutic drug monitoring. 2007, Vol 29, Num 3, pp 284-291, issn 0163-4356, 8 p.Article

The Impact of Extracorporeal Life Support and Hypothermia on Drug Disposition in Critically III Infants and ChildrenWILDSCHUT, Enno D; VAN SAET, Annewil; POKORNA, Pavla et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi-xii, 1183-1204 [21 p.]Article

Update on Pain Assessment in Sick Neonates and InfantsVAN DIJK, Monique; TIBBOEL, Dick.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, xi, 1167-1181 [14 p.]Article

Extended-interval dosing of tobramycin in neonates: Implications for therapeutic drug monitoringDE HOOG, Matthijs; MOUTON, Johan W; SCHOEMAKER, Rik C et al.Clinical pharmacology and therapeutics. 2002, Vol 71, Num 5, pp 349-358, issn 0009-9236Article

Pediatric Pharmacogenomics: A Systematic Assessment of Ontogeny and Genetic Variation to Guide the Design of Statin Studies in ChildrenWAGNER, Jonathan; STEVEN LEEDER, J.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, ix, 1017-1037 [22 p.]Article

Pharmacotherapy of Pediatric HIV InfectionRAKHMANINA, Natella; RYAN PHELPS, B.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, x, 1093-1115 [23 p.]Article

Ontogeny of midazolam glucuronidation in preterm infantsDE WILDT, Saskia N; KEARNS, Greg L; MURRY, Darryl J et al.European journal of clinical pharmacology. 2010, Vol 66, Num 2, pp 165-170, issn 0031-6970, 6 p.Article

Can Therapeutic Drug Monitoring Improve Pharmacotherapy of HIV Infection in Adolescents?RAKHMANINA, Natella Y; VAN DEN ANKER, John N; SOLDIN, Steven J et al.Therapeutic drug monitoring. 2010, Vol 32, Num 3, pp 273-281, issn 0163-4356, 9 p.Conference Paper

Population Pharmacokinetics of Lopinavir Predict Suboptimal Therapeutic Concentrations in Treatment-Experienced Human Immunodeficiency Virus-Infected ChildrenRAKHMANINA, Natella; VAN DEN ANKER, John; BAGHDASSARIAN, Aline et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 6, pp 2532-2538, issn 0066-4804, 7 p.Article

Pediatric Pharmacokinetics: Human Development and Drug DispositionFUNK, Ryan S; BROWN, Jacob T; ABDEL-RAHMAN, Susan M et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, ix, 1001-1016 [16 p.]Article

Metabolomics in the Developing Human BeingSYGGELOU, Aggeliki; LACOVIDOU, Nicoletta; ATZORI, Luigi et al.The Pediatric clinics of North America. 2012, Vol 59, Num 5, issn 0031-3955, ix-x, 1039-1058 [22 p.]Article